This statistic shows revenues of Boehringer Ingelheim's top prescription drugs from 2016 to 2019. In 2019, revenue of top product Jardiance stood at approximately 2.2 billion euros. The Boehringer Ingelheim group is one of the world's top 20 pharmaceutical companies. The company is headquartered in Ingelheim, Germany.
Revenues of Boehringer Ingelheim's top prescription drugs from 2016 to 2019
(in million euros)
Profit from additional features by authenticating your Admin account
Please authenticate by going to "My account" → "Administration".
Then you will be able to mark statistics as favourites and use personal statistics alerts.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59$39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract; Prices do not include sales tax.
Statistics on "Pharmaceutical industry in Scandinavia "
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Boehringer Ingelheim. (April 8, 2020). Revenues of Boehringer Ingelheim's top prescription drugs from 2016 to 2019 (in million euros) [Graph]. In Statista. Retrieved May 25, 2020, from https://www.statista.com/statistics/279495/boehringer-ingelheim-top-prescription-drugs/
Boehringer Ingelheim. "Revenues of Boehringer Ingelheim's top prescription drugs from 2016 to 2019 (in million euros)." Chart. April 8, 2020. Statista. Accessed May 25, 2020. https://www.statista.com/statistics/279495/boehringer-ingelheim-top-prescription-drugs/
Boehringer Ingelheim. (2020). Revenues of Boehringer Ingelheim's top prescription drugs from 2016 to 2019 (in million euros). Statista. Statista Inc.. Accessed: May 25, 2020. https://www.statista.com/statistics/279495/boehringer-ingelheim-top-prescription-drugs/
Boehringer Ingelheim. "Revenues of Boehringer Ingelheim's Top Prescription Drugs from 2016 to 2019 (in Million Euros)." Statista, Statista Inc., 8 Apr 2020, https://www.statista.com/statistics/279495/boehringer-ingelheim-top-prescription-drugs/
Boehringer Ingelheim, Revenues of Boehringer Ingelheim's top prescription drugs from 2016 to 2019 (in million euros) Statista, https://www.statista.com/statistics/279495/boehringer-ingelheim-top-prescription-drugs/ (last visited May 25, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
